Section Arrow
Quote
ARCT.NASDAQ
- Arcturus Therapeutics Holdings
Quotes are at least 15-min delayed:2025/03/28 08:23 EDT
Last
 12
+0.05 (+0.42%)
Day High 
12.215 
Prev. Close
11.95 
1-M High
17.32 
Volume 
262.11K 
Bid
11.7
Ask
12.28
Day Low
11.7487 
Open
12.04 
1-M Low
11.6 
Market Cap 
324.08M 
Currency USD 
P/E 7.2 
%Yield 3.55 
10-SMA 13.3 
20-SMA 14.27 
50-SMA 15.78 
52-W High 45 
52-W Low 11.6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.00/-4.03
Enterprise Value
349.08M
Balance Sheet
Book Value Per Share
8.89
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
205.76M
Operating Revenue Per Share
9.69
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed：2025/03/28 08:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.